Michael Samar

Michael Samar serves as Chief Financial Officer at Windgap Medical, Inc. since December 2022 and is a member of the Board of Directors and Audit Committee Chair at UNITY Biotechnology since May 2022. Additionally, Michael is the Treasurer and a Board member at OUTbio since May 2023. Previously, Michael held multiple roles including Chief Financial Officer at Assembly Biosciences, Inc. from June 2017 to August 2022 and Vice President of Finance at Acorda Therapeutics, Inc. from February 2014 to April 2017. Michael’s extensive experience in finance also includes positions at Onyx Pharmaceuticals, Agennix, Johnson & Johnson Pharmaceutical Research & Development LLC, Ford Motor Credit Company, and Bank of America. Michael holds an MBA from Villanova University and a BSBA in Finance from Bryant University.